Carly Szabo, Assistant Editor

Research may lead to gel that prevents transmission of HIV, hepatitis C and the Ebola virus.

Immunosuppressive drug linked to central nervous system lymphoma in solid organ transplant patients.

Rhabdomyosarcoma is the most common soft tissue sarcoma in children.

Study may lead to enhanced efficacy of breast cancer drugs.

Blood test offers insight into how well a drug is working during the course of cancer treatment.

Malaria protein is able to attack more than 90 percent of all tumor types.

Experts discuss issues faced by patients starting an HIV therapy regimen.

Non-Hispanic whites more likely to be diagnosed with less advanced stages of breast cancer.

Clonogenic stem cells show heightened self-renewal and differentiation capacities in multiple myeloma.

Accelerated partial breast irradiation reduces therapy into just 5 days.

Treatment used in combination with fluorouracil and leucovorin for patients with metastatic pancreatic cancer.

Treatment shows significant improvement in progression-free survival in patients with unresectable or metastatic liposarcoma or leiomyosarcoma.

Program takes advantage of neuroplasticity to train the brain to work more efficiently.

Perceived discrimination is one of the main barriers to obtaining health care services for underrepresented populations.

Carfilzomib, pomalidomide, and dexamethasone regimen safe and well tolerated during recent study.

Top stories of the week on Specialty Pharmacy Times.

Some health care systems use outdated approaches to racial categorization that obscure care disparities.

Rare ALK mutation allows patients to live an average of 4 years with the disease controlled.

Women increasingly choosing surgery to remove both breasts.

Hepatic decompensation and liver failure in patients with underlying liver cirrhosis more common with drug regimen.

Researchers hope new treatment delivery system will reduce administration down to once or twice per year.

Research may improve the design of pharmaceuticals for leukemia and other types of cancer.

Breast Cancer and the Environment Research Program will focus on racially and ethnically diverse communities and expand the study of risk factors.

Panel discusses treatment barriers during annual NASP conference.

Factor X deficiency prevents blood from clotting properly.

Despite new advanced immunotherapies, surgical resection still is the most effective treatment for abdominal metastatic melanoma.

Existing medications and myxoma virus combination shows promise against glioblastoma.

Process responsible for cancer cell proliferation uncovered.

HDAC inhibitors stop the activation of genes that turn normal cells into cancerous cells.

Researchers raise concerns that studies reporting negative results are not published, leading to overestimated drug efficacy.